女性器官癌症仍然是中国乃至全世界的沉重负担。 GLOBOCAN 2022 最近更新了癌症负担的估计。本研究旨在描绘疾病负担概况，并比较中国与其他国家女性器官癌症的年龄别发病率。提取了不同地区和国家女性器官癌症发病率和死亡率的最新估计值来自 GLOBOCAN 2022 数据库。我们比较了中国和全球六种女性器官癌症和其他肿瘤类型的总病例或死亡比例。进行相关分析以评估年龄标准化发病率（ASIR）或年龄标准化死亡率（ASMR）与人类发展指数（HDI）之间的关系。此外，还绘制了十个不同收入水平的示范国家的年龄特定发病率曲线。在全球范围内，女性器官癌症的负担各不相同，北美的发病率较高，非洲的宫颈癌发病率较高。由于女性器官癌症在六种肿瘤中所占比例较大，因此仍然是中国的一个重大负担。研究发现，社会经济发展与乳腺癌、子宫体癌、卵巢癌和外阴癌的发病率呈正相关，而人类发展指数（HDI）等级与宫颈癌和阴道癌的死亡率呈负相关。 2022年，50-54岁的中国女性乳腺癌、宫颈癌、子宫体癌和卵巢癌的发病率很高。女性器官癌症仍然是中国和全球女性的一个重大健康问题。实施针对年轻人日益增长的趋势并减少地区差异的综合预防策略至关重要。版权所有 © 2024 中华医学会，由 Wolters Kluwer, Inc. 根据 CC-BY-NC-ND 许可制作。

Cancers in female organs remain a substantial burden in China and worldwide. GLOBOCAN 2022 has recently updated the estimates of cancer burden. This study aims to depict the profiles of disease burden and to compare the age-specific rates of cancers in female organs in China with those in other countries.The latest estimates of incidence and mortality of cancers in female organs from various regions and countries were extracted from the GLOBOCAN 2022 database. We compared the proportion of total cases or deaths for cancers affecting six female organs and other tumor types in China and globally. Correlation analysis was conducted to evaluate the relationship between age-standardized incidence rate (ASIR) or age-standardized mortality rate (ASMR) and the Human Development Index (HDI). Additionally, age-specific rate curves were plotted for ten exemplary countries with different income levels.Globally, there are varying burdens of female organ cancers, with higher incidence rates in Northern America and elevated rates of cervical cancer in Africa. Female organ cancers in China remain a significant burden due to their large proportion of the six tumors. A positive correlation between socioeconomic development and the incidence of breast, uterine corpus, ovarian, and vulvar cancers was noted, whereas a negative association between the HDI tiers and mortality rates was found for cervical and vaginal cancers. In 2022, Chinese women aged 50-54 years are experiencing high incidence rates of breast, cervix uteri, corpus uteri, and ovarian cancers.Cancers in female organs continue to be a significant health concern for women in China and worldwide. It is crucial to implement comprehensive prevention strategies tailored to address the increasing trend among younger individuals and reduce regional disparities.Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.